Most recently, it's been identified that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to some big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger and isn't going to activate a next me